SCHEMBL7843515

SCHEMBL7843515

NS(=O)(=O)c1ccc(-c2sc(C(=O)Nc3cc(Cl)cc(Cl)c3)nc2-c2ccc(F)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.58
PTGS1 P23219 8/20 0.58
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
CA4 P22748 3/20 0.48
CA7 P43166 3/20 0.48
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7842908 1.00 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA4
SCHEMBL7846064 0.91 PTGS2 (0.59) PTGS2PTGS1CA1CA2CA4
SCHEMBL7843501 0.91 PTGS2 (0.59) PTGS2PTGS1CA1CA2CA4
SCHEMBL7845603 0.91 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA4
SCHEMBL7845614 0.91 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA4
SCHEMBL7843989 0.91 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA4
SCHEMBL7842841 0.91 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA4
SCHEMBL7832323 0.90 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7844347 0.90 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7843932 0.89 CA2 (0.58) PTGS2PTGS1CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
US-5668161-A Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 1997-09-16 US disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed